Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-20
DOI
10.1007/s00262-019-02475-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
- (2018) She-Gan Gao et al. BMC CANCER
- Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study
- (2018) L.C. Hewitt et al. EUROPEAN JOURNAL OF CANCER
- Targeting CD38 to improve anti-PD-1/CTLA-4 combination therapy in lung cancer.
- (2018) Limo Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
- (2018) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- TIM-3, a promising target for cancer immunotherapy
- (2018) Yayi He et al. OncoTargets and Therapy
- Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
- (2017) Jessica Roelands et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
- (2017) Josefa A. Rodríguez Oncology Letters
- Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
- (2017) Elly Marcq et al. Oncotarget
- Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer
- (2017) Armin Jarosch et al. OncoImmunology
- Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
- (2017) H. van Meir et al. OncoImmunology
- Immunotherapy and tumor microenvironment
- (2016) Haidong Tang et al. CANCER LETTERS
- Opportunities for Preventing Esophageal Adenocarcinoma
- (2016) John Maret-Ouda et al. Cancer Prevention Research
- The emerging role of immunotherapy in gastric and esophageal adenocarcinoma
- (2016) Bruno Bockorny et al. Future Oncology
- Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis
- (2016) Basile Njei et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny
- (2015) Harit Kapoor et al. Translational Research
- Oncogenic cancer/testis antigens: prime candidates for immunotherapy
- (2015) Morten F. Gjerstorff et al. Oncotarget
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Recent developments in esophageal adenocarcinoma
- (2013) Jesper Lagergren et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Oesophageal cancer survival in Europe: A EUROCARE-4 study
- (2012) A.T. Gavin et al. Cancer Epidemiology
- Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
- (2012) Brian M Olson et al. Expert Review of Vaccines
- A global assessment of the oesophageal adenocarcinoma epidemic
- (2012) Gustaf Edgren et al. GUT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started